Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

J&J puts pressure on rivals with new Erleada okay in prostate cancer

J&J puts pressure on rivals with new Erleada okay in prostate cancer Since then, Bayer and Orion’s  Nubeqa(darolutamide) has also joined the fray in nmCRPC after an FDA approval in July, adding to the competitive pressure in that indication.

Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications

Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications insights. According to Uwe Dalichow, Head of Global Marketing Operations, Bayer: “Data analytics is the springboard for meaningful applications of next-gen AI and ML technology.

New hires at Bayer, Eisai and Accord Healthcare

New hires at Bayer, Eisai and Accord Healthcare The latest movers in pharma. Bayer appoints new head of pharma business development &licensing. ... Bayer has bolstered its pharma division, appointing Marianne De Backer (pictured below) as its new head of business development &licensing.

Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO

Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO The company has just picked up a new approval for targeted cancer drug Rozlytrek(entrectinib), a rival to Bayer’s Vitrakvi (larotrectinib), and for anti-CD79b antibody drug conjugate Polivy (polatuzumab

Roche undercuts price of Bayer cancer drug after winning FDA approval

Roche undercuts price of Bayer cancer drug after winning FDA approval Vitrakvi, which Bayer acquired from Loxo Oncology, won approval in patients with NTRK gene fusions in November. ... Roche could derail Bayer’s progress, however, in part because of its willingness to compete on price.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics